$name
$name

Science & Innovation 06.29.2021

AtlanticLIVE and Amgen Highlight Inequities in Lung Cancer and the Importance of Biomarker Testing

Read More
Arrow
❮1 / 6❯
$name
$name

Science & Innovation 05.28.2021

Perspectives From the Community: A Fireside Chat With Andrea Ferris, President and CEO of LUNGevity

Watch Video
Arrow
❮2 / 6❯
$name
$name

Science & Innovation 05.28.2021

Non-Small Cell Lung Cancer (NSCLC) and KRAS G12C: Fast Facts

Read More
Arrow
❮3 / 6❯
$name
$name

Science & Innovation 05.28.2021

The Precision Medicine Revolution in NSCLC: Featuring Dr. Suresh Ramalingam, Deputy Director, Winship Cancer Institute of Emory University

Watch Video
Arrow
❮4 / 6❯
$name
$name

Patients 04.15.2021

Every Patient’s Cancer is Unique

Featuring Terri Conneran, a lung cancer patient advocate and founder of the advocacy group KRAS Kickers
Watch Video
Arrow
❮5 / 6❯
$name
$name

Science & Innovation 04.12.2021

Driver Mutations Explained

Featuring Dr. Upal Basu Roy, Vice President of Research, The LUNGevity Foundation
Watch Video
Arrow
❮6 / 6❯

Taking on KRAS G12C

$link.Title
SCIENCE & INNOVATION 03.01.2022

Increasing Communication and Collaboration Among Cancer Care Teams to Improve Biomarker Testing in NSCLC
$link.Title
SCIENCE & INNOVATION 01.29.2021

From Oncogene Discovery to KRAS Inhibitor
$link.Title
PATIENTS 12.07.2020

Rapid Innovation in Lung Cancer, From a Patient’s Perspective
$link.Title
SCIENCE & INNOVATION 09.18.2020

For People With Lung Cancer, Expanded Biomarker Testing Is Key to Advancing Science
More Science and Innovation Stories

KRAS Conversations

Learn More About KRAS G12C

Targeting KRAS G12C in Cancer Targeting KRAS G12C in Cancer

Targeting KRAS G12C in Cancer
Biomarker Testing: Know your Lung Cancer Biomarker Testing: Know your Lung Cancer

Biomarker Testing in Lung Cancer
toughest-challeges-video-kras-desktoptoughest-challeges-video-kras-mobile

Video: KRAS G12C Mechanism of Disease
Lungs and Genetic Testingfast-facts-lungs-genetic-testing-314x190

Understanding KRAS G12C in Non-Small Cell Lung Cancer

Follow Amgen Oncology on Twitter and LinkedIn for the latest updates and learn more about Amgen's commitment to the relentless pursuit of breakthroughs for cancer patients with NSCLC and other solid tumors with KRAS G12C mutations at AmgenOncology.com.